Celularity (NASDAQ: CELU) terminates employment of chief commercial officer
Rhea-AI Filing Summary
Celularity Inc. removed a key member of its senior leadership team. On August 5, 2026, the company terminated the employment of Rick Gonzalez, who served as its Chief Commercial Officer, effective immediately. As of that date, he ceased serving in that role.
The report is executed on behalf of Celularity by K. Harold Fletcher, its Chief Legal and Strategy Officer. Celularity is incorporated in Delaware and maintains its principal executive offices at 170 Park Ave, Florham Park, New Jersey 07932.
Positive
- None.
Negative
- Termination of Chief Commercial Officer: Celularity ended the employment of its Chief Commercial Officer, Rick Gonzalez, effective August 5, 2026, creating an immediate vacancy in a senior commercial leadership role.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Effective date of termination: August 5, 2026
Signature date: August 7, 2026
Main telephone number: (908) 768-2170
3 metrics
Effective date of termination
August 5, 2026
Date Celularity terminated the employment of Chief Commercial Officer Rick Gonzalez
Signature date
August 7, 2026
Date the report was signed by Chief Legal and Strategy Officer K. Harold Fletcher
Main telephone number
(908) 768-2170
Registrant’s listed telephone number for Celularity’s principal executive offices
Key Terms
Emerging growth company, Section 12(b) of the Act, Chief Commercial Officer
3 terms
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Section 12(b) of the Act regulatory
"Securities registered pursuant to Section 12(b) of the Act"
Chief Commercial Officer financial
"terminated the employment of Rick Gonzalez, the Company’s Chief Commercial Officer, effective immediately"
A chief commercial officer (CCO) is the senior executive responsible for a company’s revenue-generating activities, including sales, marketing, pricing, customer relationships and business development. Think of the CCO as the head coach who builds the game plan to win customers and grow sales; their effectiveness affects how fast a company earns money, enters new markets and sustains profits, making the role a key signal for investors about future revenue and competitive strength.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What executive change did Celularity (CELU) disclose on August 5, 2026?
Celularity disclosed that it terminated the employment of Rick Gonzalez, its Chief Commercial Officer, effective August 5, 2026. As of that date, Gonzalez ceased serving in the Chief Commercial Officer role at the company.
What role did Rick Gonzalez hold at Celularity (CELU) before his termination?
Before his termination, Rick Gonzalez served as Celularity’s Chief Commercial Officer. Celularity stated that his employment was terminated effective August 5, 2026, and that he ceased serving in this senior commercial leadership position on that date.
When did the termination of Rick Gonzalez’s employment at Celularity (CELU) become effective?
The termination of Rick Gonzalez’s employment at Celularity became effective August 5, 2026. Celularity noted that, as of that date, he ceased serving as the company’s Chief Commercial Officer, indicating an immediate leadership change.
Who signed the leadership change report on behalf of Celularity (CELU)?
The report documenting the leadership change was signed by K. Harold Fletcher, Celularity’s Chief Legal and Strategy Officer. He signed on behalf of Celularity, with a signature date of August 7, 2026, in his authorized corporate capacity.
Where is Celularity (CELU) headquartered and what is its main contact number?
Celularity’s principal executive offices are at 170 Park Ave, Florham Park, New Jersey 07932. The company lists its main telephone number as (908) 768-2170, providing a primary point of contact for business and investor inquiries.